Bisecting GlcNAc expression by bone marrow stromal cells modulates TGF-β1-driven macrophage polarization in myeloid leukemias

Accumulating evidence have highlighted the critical role of tumor-associated macrophages (TAMs) in promoting immune evasion and disease progression in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Combined single-cell RNA sequencing, flow cytometry, and immunohistochemistry stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Jingjing Feng, Junjie Gou, Yi Wang, Wei Wei, Yihan Ma, Xueting Ren, Chongfu Zhao, Xiaoliang Cheng, Lei Lei, Zengqi Tan, Feng Guan, Xiang Li
Format: Article
Language:English
Published: Ferrata Storti Foundation 2025-05-01
Series:Haematologica
Online Access:https://haematologica.org/article/view/12071
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Accumulating evidence have highlighted the critical role of tumor-associated macrophages (TAMs) in promoting immune evasion and disease progression in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS). Combined single-cell RNA sequencing, flow cytometry, and immunohistochemistry studies of the innate immune compartment in bone marrow of MDS/AML reveal a shift toward a tumor-supportive M2-polarized macrophage as well as the expression of programmed cell death-ligand 1 (PD-L1) in this cell lineage. We found the leukemic stroma cells with high level of TGFβ1 secretion can determine TAMs toward M2-polarized subtype. Further mechanistic investigations revealed that bone marrow stromal cells with specific glycans, reduced bisecting N-acetylglucosamine (GlcNAc) levels, in MDS/AML promoted M2-polarized subtype through the secretion of TGFβ1, which elevated PD-L1 expression and thereby impaired CD8+ T cell function. Our study provides insights into the mechanisms of selectively modifying specific glycans in bone marrow stroma cells may contribute to targeting strategies aimed at the tumor microenvironment.
ISSN:0390-6078
1592-8721